
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1039 | 1031 | 1101 | 989 | 1514 | - |
Fund Return | 3.89% | 3.1% | 10.05% | -0.38% | 8.65% | - |
Place in category | 401 | 398 | 212 | 328 | 63 | - |
% in Category | 89 | 89 | 53 | 86 | 14 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Eurose Class I shares E | 2.36B | 1.82 | 3.87 | 2.78 | ||
DNCA Invest Eurose Class AD shares | 2.36B | 1.77 | 3.13 | 2.05 | ||
DNCA Invest Eurose Class A shares | 2.36B | 1.77 | 3.14 | 2.05 | ||
DNCA Invest Europe Growth Class A s | 838.47M | 6.14 | 0.98 | 6.27 | ||
DNCA Invest Europe Growth Class B s | 838.47M | 6.08 | 0.58 | 5.88 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Europe Growth Class A s | 821.67M | 6.14 | 0.98 | 6.27 | ||
DNCA Invest Europe Growth Class B s | 821.67M | 6.08 | 0.58 | 5.88 | ||
DNCA Invest Europe Growth Class F s | 821.67M | 6.35 | 2.23 | 7.41 | ||
DNCA Invest Europe Growth Class I s | 821.67M | 6.32 | 2.02 | 7.28 | ||
LU1330191385 | 795.79M | 8.75 | 10.76 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.71 | 530.5 | -3.44% | |
Flutter Entertainment | IE00BWT6H894 | 6.66 | 17,900.0 | +0.34% | |
Bonesupport | SE0009858152 | 5.41 | 315.80 | -0.69% | |
SAP | DE0007164600 | 5.28 | 238.650 | -1.47% | |
Tryg | DK0060636678 | 5.01 | 157.9 | +0.77% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review